Edit

deCODE Genetics

https://www.decode.com/company/

Last activity: 21.05.2025

Active

Categories: BioTechDatabaseDiagnosticsHumanInformationResearch

deCODE genetics is a global leader in analysing and understanding the human genome. Using its unique expertise and population resources, deCODE has discovered genetic risk factors for dozens of common diseases. The purpose of understanding the genetics of disease is to use that information to create new means of diagnosing, treating and preventing disease

Followers

3.99K

Website visits

13.1K /mo.

Mentions

Location: Iceland, Reykjavik

Employees: 201-500

Total raised: $75M

Founded date: 1996

Founders Related Locations: Iceland, Reykjavik; United States, Massachusetts, Boston; United States, Massachusetts, Cambridge

Investors 3

Date	Name	Website
17.07.2021	ARCH Ventu...	archventur...
-	Hercules C...	htgc.com
-	Illumina V...	illuminaVe...

Mentions in press and media 25

Date	Title	Description
21.05.2025	Lethal mutations in pregnancy loss	REYKJAVIK, Iceland, May 21, 2025 /PRNewswire/ -- In a study published in Nature today "Sequence diversity lost in early pregnancy," scientists from deCODE genetics, a subsidiary of Amgen, estimate that around one in 136 pregnancie...
27.03.2025	Unraveling the Genetic Threads of Bipolar Disorder and the Future of Healthcare Advertising	In the intricate tapestry of human health, two recent developments stand out. One reveals the genetic underpinnings of bipolar disorder, while the other transforms healthcare advertising through cutting-edge technology. Together, they highl...
25.03.2025	Rare loss-of-function variants in HECTD2 and AKAP11 confer a risk of bipolar disorder	Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare loss-of-function variants in two genes and bipolar disorder. REYKJAVIK, Iceland, March 25, 2025 /PRNewswire/ -- Bipolar disorder...
23.01.2025	deCODE genetics: Complete recombination map of the human-genome, a major step in genetics	REYKJAVIK, Iceland, Jan. 23, 2025 /PRNewswire/ -- Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction. The map marks a major step in the understanding of gen...
12.11.2024	deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk	REYKJAVIK, Iceland, Nov. 12, 2024 /PRNewswire/ -- New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower the risk of several diseases. Scientists at d...
29.10.2024	Discovery of cancer risk associations for six novel genes	REYKJAVIK, Iceland, Oct. 29, 2024 /PRNewswire/ --Scientists at deCODE genetics/Amgen, and their collaborators have discovered six novel genes with rare germline variants that associate with cancer risk. The findings are published today in N...
28.07.2024	The Quantum Leap: Quantinuum's Path to IPO and the Future of Computing	In the fast-paced world of technology, few sectors are as electrifying as quantum computing. At the forefront of this revolution is Quantinuum, a company poised to make waves with its impending IPO. This move could redefine the landscape of...
24.07.2024	deCODE genetics: Variants in the genome affect DNA methylation	REYKJAVIK, Iceland, July 24, 2024 /PRNewswire/ -- A new study by scientists at deCODE Genetics, subsidiary of Amgen, shows that sequence variants drive the correlation between DNA methylation and gene expression. The same variants are linke...
07.06.2024	deCODE genetics: The rate, nature and transmission of mitochondrial DNA mutations in humans	A new study from deCODE genetics uses pedigrees and sequence data from 64,806 Icelanders to shed light on the rate and nature of mutations in mitochondrial DNA (mtDNA) and the peculiar dynamics of its maternal transmission REYKJAVIK, Icelan...
13.04.2022	BioCertica, an African genetics company, has raised $1.6 million in a seed round	BioCertica has announced a $1.6 million seed round, following a $650,000 pre-seed round. Ministry of Programming (MOP), the pre-seed round’s principal investor and technology partner, established and constructed bespoke genetic pipelines ta...
12.04.2022	African genetics company raises $1.6m seed round	Billed as the first African-based direct-to-consumer genetics company to introduce polygenic risk scoring (PRS) to generate DNA test results, BioCertica has just launched a $1.6 million seed round after raising $650 000 in pre-seed funding....
12.04.2022	African genetics company raises $1.6m seed round	Billed as the first African-based direct-to-consumer genetics company to introduce polygenic risk scoring (PRS) to generate DNA test results, BioCertica has just launched a $1.6 million seed round after raising $650 000 in pre-seed funding....
01.09.2020	Humoral immune response to SARS-CoV2 in Iceland USA - English España - español Latin America - español Brazil - Português
26.10.2016	GMI Raises $40M Series A from ARCH Venture	Irish life-sciences startup, Genomics Medicine Ireland (GMI) has secured Series A investment of $40 million from sovereign and international investors including ARCH Venture Partners, Polaris Partners, the Ireland Strategic Investment Fund,...
26.10.2016	Genomics Medicine Ireland raises $40 million for large-scale genomic research	Irish Taoiseach (Prime Minister) Enda Kenny formally announced the news, highlighting the local economic impact he believes GMI could have. “When the Government established the ISIF, we wanted to encourage new investment and job creation ac...
26.10.2016	GMI Raises $40M Series A from GV	Irish life-sciences startup, Genomics Medicine Ireland (GMI) has secured Series A investment of $40 million from sovereign and international investors including ARCH Venture Partners, Polaris Partners, the Ireland Strategic Investment Fund,...
07.04.2015	Should People Be Told Key Results Of Genetic Tests They Never Took?	The population of Iceland is unusual in a number of ways. Icelanders are descendants from a relatively small group of early settlers that remained isolated for hundreds of years. They have unmatched genealogical records that allow the famil...
12.10.2011	Pfizer, deCode Genetics Strike Deal To Look For New Lupus Drug Targets	Share Share on Facebook Share on Twitter LinkedIn Email Reprints Companies like Pfizer that constantly need to develop new drugs never got much return on the investment in genomics a decade ago. But Pfizer is showing some renewed interest i...
24.08.2009	Complete Genomics seals $45M for cheaper gene sequencing	Complete Genomics, provider of supposedly cheaper and faster DNA sequencing services, has raised $45 million in a fourth round of funding — a huge amount for a biotech company in today’s economic environment. Based in Mountain View, Calif.,...
24.08.2009	Complete Genomics seals $45M for cheaper gene sequencing	We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! Complete Genomics, provider of supposedly cheaper...
26.01.2008	deCODEme and its questionable disease-risk predictions	(UPDATED: Original final paragraphs on 23andMe broken out as a separate post here.) A few days ago, I noted that deCODEme, the personal-genomics spinoff of Iceland’s deCODE Genetics, looks to be offering disease-risk predictions based on su...
06.12.2007	Life sciences briefing: Thursday, Dec. 6, 2007	(UPDATED: Expanded items on LineaGen, BG Medicine. Pelikan Tech is described in a standalone item here.) TODAY’S HEADLINES: Pelikan Tech raises $69M for diabetes glucose tests (release) Utah’s LineaGen draws $6M for genetic diagnostics (Ven...
17.11.2007	23andMe lets you search and share your genome — today	(UPDATED: See below.) Personal genomics is finally here. 23andMe, the Google-backed startup that promises to let individuals search and share their personal genetic information, just unveiled its service on its Web site. (A formal announcem...
-	BioCertica, an African genetics company, has raised $1.6 million in a seed round	BioCertica has announced a $1.6 million seed round, following a $650,000 pre-seed round. Ministry of Programming (MOP), the pre-seed round’s principal investor and technology partner, established and constructed bespoke genetic pipelines ta...
-	Genomics Medicine Ireland raises $40 million for large-scale genomic research	GMI Co-Founders, Dan Crowley, Paul Thurk, Sean Ennis, Maurice Treacy and Irish PM, Enda Kenny The 4.7 million-strong Irish population will soon be under the genomic microscope, following a $40 million series A funding round by Genomics Medi...

deCODE Genetics

Investors 3

Mentions in press and media 25

Reviews 0